Welcome to LookChem.com Sign In|Join Free
  • or
(S)-(+)-1-Aminoindan, also known as the S-enantiomer of 1-Aminoindane, is a clear yellow liquid that serves as a metabolite of the monoamine oxidase-B inhibitor Rasagiline (R126000). (S)-(+)-1-Aminoindan plays a significant role in the pharmaceutical industry due to its association with the metabolism of Rasagiline, which is a drug used to treat Parkinson's disease.

61341-86-4

Post Buying Request

61341-86-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61341-86-4 Usage

Uses

Used in Pharmaceutical Industry:
(S)-(+)-1-Aminoindan is used as a metabolite in the development and study of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease. Its role in the metabolism of Rasagiline contributes to the understanding of the drug's efficacy and potential side effects, aiding in the improvement of treatment options for patients.
Additionally, as a metabolite of a known drug, (S)-(+)-1-Aminoindan may also be used as a reference compound in the synthesis and quality control of pharmaceutical products, ensuring the purity and effectiveness of medications derived from or related to Rasagiline.
Used in Research and Development:
In the field of neuroscience and neurodegenerative disease research, (S)-(+)-1-Aminoindan is used as a research compound to study the mechanisms of action and metabolic pathways of Rasagiline. This helps scientists to better understand the drug's impact on the brain and its potential for treating other neurological conditions beyond Parkinson's disease.
Furthermore, the compound may be utilized in the development of new drugs with similar mechanisms of action, potentially leading to the discovery of novel treatments for a range of neurological disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 61341-86-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,3,4 and 1 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 61341-86:
(7*6)+(6*1)+(5*3)+(4*4)+(3*1)+(2*8)+(1*6)=104
104 % 10 = 4
So 61341-86-4 is a valid CAS Registry Number.

61341-86-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L19303)  (S)-(+)-1-Aminoindane, ChiPros 99+%, ee 99+%   

  • 61341-86-4

  • 1g

  • 888.0CNY

  • Detail
  • Alfa Aesar

  • (L19303)  (S)-(+)-1-Aminoindane, ChiPros 99+%, ee 99+%   

  • 61341-86-4

  • 5g

  • 3396.0CNY

  • Detail
  • Aldrich

  • (445355)  (S)-(+)-1-Aminoindan  97%

  • 61341-86-4

  • 445355-250MG

  • 617.76CNY

  • Detail
  • Aldrich

  • (445355)  (S)-(+)-1-Aminoindan  97%

  • 61341-86-4

  • 445355-1G

  • 1,942.20CNY

  • Detail
  • Aldrich

  • (727083)  (S)-(+)-1-Aminoindan  ChiPros®, produced by BASF, 99%

  • 61341-86-4

  • 727083-25G

  • 11,711.70CNY

  • Detail

61341-86-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-(+)-1-Aminoindane

1.2 Other means of identification

Product number -
Other names (1S)-2,3-dihydro-1H-inden-1-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61341-86-4 SDS

61341-86-4Relevant academic research and scientific papers

Enantioselective synthesis of 1-aminoindene derivativesviaasymmetric Br?nsted acid catalysis

Ding, Du,Jiang, Hua-Jie,Wang, Tao,Wu, Xiang,Zhang, Ying,Zhao, Li-Ping

supporting information, p. 9680 - 9683 (2021/09/30)

We describe a catalytic asymmetric iminium ion cyclization reaction of simple 2-alkenylbenzaldimines using a BINOL-derived chiralN-triflyl phosphoramide. The corresponding 1-aminoindenes and tetracyclic 1-aminoindanes are formed in good yields and high enantioselectivities. Further, the chemical utility of the obtained enantiopure 1-aminoindene is demonstrated for the asymmetric synthesis of (S)-rasagiline.

Engineering the large pocket of an (S)-selective transaminase for asymmetric synthesis of (S)-1-amino-1-phenylpropane

Liu, He,Wang, Hualei,Wei, Dongzhi,Xie, Youyu,Xu, Feng,Xu, Xiangyang,Yang, Lin

, p. 2461 - 2470 (2021/04/22)

Amine transaminases offer an environmentally benign chiral amine asymmetric synthesis route. However, their catalytic efficiency towards bulky chiral amine asymmetric synthesis is limited by the natural geometric structure of the small pocket, representing a great challenge for industrial applications. Here, we rationally engineered the large binding pocket of an (S)-selective ?-transaminase BPTA fromParaburkholderia phymatumto relieve the inherent restriction caused by the small pocket and efficiently transform the prochiral aryl alkyl ketone 1-propiophenone with a small substituent larger than the methyl group. Based on combined molecular docking and dynamic simulation analyses, we identified a non-classical substrate conformation, located in the active site with steric hindrance and undesired interactions, to be responsible for the low catalytic efficiency. By relieving the steric barrier with W82A, we improved the specific activity by 14-times compared to WT. A p-p stacking interaction was then introduced by M78F and I284F to strengthen the binding affinity with a large binding pocket to balance the undesired interactions generated by F44. T440Q further enhanced the substrate affinity by providing a more hydrophobic and flexible environment close to the active site entry. Finally, we constructed a quadruple variant M78F/W82A/I284F/T440Q to generate the most productive substrate conformation. The 1-propiophenone catalytic efficiency of the mutant was enhanced by more than 470-times in terms ofkcat/KM, and the conversion increased from 1.3 to 94.4% compared with that of WT, without any stereoselectivity loss (ee > 99.9%). Meanwhile, the obtained mutant also showed significant activity improvements towards various aryl alkyl ketones with a small substituent larger than the methyl group ranging between 104- and 230-fold, demonstrating great potential for the efficient synthesis of enantiopure aryl alkyl amines with steric hindrance in the small binding pocket.

Kinetic Resolution of Racemic Primary Amines Using Geobacillus stearothermophilus Amine Dehydrogenase Variant

Tseliou, Vasilis,Knaus, Tanja,Vilím, Jan,Masman, Marcelo F.,Mutti, Francesco G.

, p. 2184 - 2188 (2020/03/11)

A NADH-dependent engineered amine dehydrogenase from Geobacillus stearothermophilus (LE-AmDH-v1) was applied together with a NADH-oxidase from Streptococcus mutans (NOx) for the kinetic resolution of pharmaceutically relevant racemic α-chiral primary amines. The reaction conditions (e. g., pH, temperature, type of buffer) were optimised to yield S-configured amines with up to >99 % ee.

Enzymatic Primary Amination of Benzylic and Allylic C(sp3)-H Bonds

Jia, Zhi-Jun,Gao, Shilong,Arnold, Frances H.

supporting information, p. 10279 - 10283 (2020/07/27)

Aliphatic primary amines are prevalent in natural products, pharmaceuticals, and functional materials. While a plethora of processes are reported for their synthesis, methods that directly install a free amine group into C(sp3)-H bonds remain unprecedented. Here, we report a set of new-to-nature enzymes that catalyze the direct primary amination of C(sp3)-H bonds with excellent chemo-, regio-, and enantioselectivity, using a readily available hydroxylamine derivative as the nitrogen source. Directed evolution of genetically encoded cytochrome P411 enzymes (P450s whose Cys axial ligand to the heme iron has been replaced with Ser) generated variants that selectively functionalize benzylic and allylic C-H bonds, affording a broad scope of enantioenriched primary amines. This biocatalytic process is efficient and selective (up to 3930 TTN and 96percent ee), and can be performed on preparative scale.

Chemoenzymatic Synthesis of a Chiral Ozanimod Key Intermediate Starting from Naphthalene as Cheap Petrochemical Feedstock

Uthoff, Florian,L?we, Jana,Harms, Christina,Donsbach, Kai,Gr?ger, Harald

, p. 4856 - 4866 (2019/05/02)

Ozanimod represents a recently developed, promising active pharmaceutical ingredient (API) molecule in combating multiple sclerosis. Addressing the goal of a scalable, economically attractive, and technically feasible process for the manufacture of this drug, a novel alternative synthetic approach toward (S)-4-cyano-1-aminoindane as a chiral key intermediate for ozanimod has been developed. The total synthesis of this intermediate is based on the utilization of naphthalene as a readily accessible, economically attractive, and thus favorable petrochemical starting material. At first, naphthalene is transformed into 4-carboxy-indanone within a four-step process by means of an initial Birch reduction, followed by an isomerization of the C=C double bond, oxidative C=C cleavage, and intramolecular Friedel-Crafts acylation. The transformation of the 4-carboxy-indanone into (S)-4-cyano-1-aminoindane then represents the key step for introducing the chirality and the desired absolute S configuration. When evaluating complementary biocatalytic approaches based on the use of a lipase and transaminase, respectively, the combination of a chemical reductive amination of the 4-carboxyindanone followed by a subsequent lipase-catalyzed resolution turned out to be the most efficient route, leading to the desired key intermediate (S)-4-cyano-1-aminoindane in satisfactory yield and with excellent enantiomeric excess of 99%.

Kinetic Resolution and Deracemization of Racemic Amines Using a Reductive Aminase

Aleku, Godwin A.,Mangas-Sanchez, Juan,Citoler, Joan,France, Scott P.,Montgomery, Sarah L.,Heath, Rachel S.,Thompson, Matthew P.,Turner, Nicholas J.

, p. 515 - 519 (2018/02/15)

The NADP(H)-dependent reductive aminase from Aspergillus oryzae (AspRedAm) was combined with an NADPH oxidase (NOX) to develop a redox system that recycles the co-factor. The AspRedAm-NOX system was applied initially for the kinetic resolution of a variety of racemic secondary and primary amines to yield S-configured amines with enantiomeric excess (ee) values up to 99 %. The addition of ammonia borane to this system enabled the efficient deracemization of racemic amines, including the pharmaceutical drug rasagiline and the natural product salsolidine, with conversions up to >98 % and >99 % ee Furthermore, by using the AspRedAm W210A variant it was possible to generate the opposite R enantiomers with efficiency comparable to, or even better than, the wildtype AspRedAm.

Simultaneous engineering of an enzyme's entrance tunnel and active site: The case of monoamine oxidase MAO-N

Li, Guangyue,Yao, Peiyuan,Gong, Rui,Li, Jinlong,Liu, Pi,Lonsdale, Richard,Wu, Qiaqing,Lin, Jianping,Zhu, Dunming,Reetz, Manfred T.

, p. 4093 - 4099 (2017/07/10)

A new directed evolution approach is presented to enhance the activity of an enzyme and to manipulate stereoselectivity by focusing iterative saturation mutagenesis (ISM) simultaneously on residues lining the entrance tunnel and the binding pocket. This combined mutagenesis strategy was applied successfully to the monoamine oxidase from Aspergillus Niger (MAO-N) in the reaction of sterically demanding substrates which are of interest in the synthesis of chiral pharmaceuticals based on the benzo-piperidine scaffold. Reversal of enantioselectivity of Turner-type deracemization was achieved in the synthesis of (S)-1,2,3,4-tetrahydro-1-methyl-isoquinoline, (S)-1,2,3,4-tetrahydro-1-ethylisoquinoline and (S)-1,2,3,4-tetrahydro-1-isopropylisoquinoline. Extensive molecular dynamics simulations indicate that the altered catalytic profile is due to increased hydrophobicity of the entrance tunnel acting in concert with the altered shape of the binding pocket.

Dynamic power learning split preparation (S)- 1 - amino indane

-

, (2017/07/04)

The invention relates to a preparation method of optically pure (S)-1-aminoindane. The preparation method comprises steps as follows: 1-aminoindane is taken as a raw material, a solvent, Candida rugose lipase, an acyl donor L-(+)-O-acetyl mandelic acid and a racemization catalyst KT-02 are added to a high pressure kettle in proportion, hydrogen is introduced, all components react for a period of time, and then 1-aminoindane can be completely converted into an acetyl compound of (S)-1-aminoindane. A product is purified and subjected to acid hydrolysis and alkali free operation, (S)-1-aminoindane is obtained, and an ee value of a final product is larger than 99%. The preparation method has the characteristics that the operation is simple, the racemization catalyst is cheap and available, the raw material is completely utilized, the optical purity of the product is high and the like; the preparation method has great guidance and application value in the aspect of production and preparation of (S)-1-aminoindane.

A stereoselective, catalytic strategy for the in-flow synthesis of advanced precursors of rasagiline and tamsulosin

Brenna, Davide,Pirola, Margherita,Raimondi, Laura,Burke, Anthony J.,Benaglia, Maurizio

supporting information, p. 6242 - 6247 (2017/09/30)

The diastereoselective, trichlorosilane-mediate reduction of imines, bearing different and removable chiral auxiliaries, in combination either with achiral bases or catalytic amounts of chiral Lewis bases, was investigated to afford immediate precursors of chiral APIs (Active Pharmaceutical Ingredients). The carbon-nitrogen double bond reduction was successfully performed in batch and in flow mode, in high yields and almost complete stereocontrol. By this metal-free approach, the formal synthesis of rasagiline and tamsulosin was successfully accomplished in micro(meso) flow reactors, under continuous flow conditions. The results of these explorative studies represent a new, important step towards the development of automated processes for the preparation of enantiopure biologically active compounds.

Asymmetric hydrogenation of 2,3-dihydro-1H-inden-1-one oxime and derivatives

Maj, Anna M.,Suisse, Isabelle,Agbossou-Niedercorn, Francine

, p. 268 - 273 (2017/03/01)

Asymmetric hydrogenation of 2,3-dihydro-1H-inden-1-one oxime and derivatives to produce the corresponding optically active amine has been performed in the presence of rhodium and iridium catalysts. The optimization of neutral rhodium based catalytic syste

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61341-86-4